Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 151 to 165 of 496 results for 2011

  1. Are interventions for psychosis or substance misuse clinically and cost effective when compared with standard care for people with psychosis and coexisting substance misuse?

    in healthcare settings Number CG120 Date issued March 2011 Other details Is this a recommendation for the use

    Research recommendation
    Published
    9 June 2015

  2. How do socioeconomic, environmental, biological and psychosocial factors determine diet and physical activity behaviours and how do they contribute to differences in the risk of developing type 2 diabetes?

    community-level interventions Number PH35 Date issued May 2011 Other details Is this a recommendation for the use

    Research recommendation
    Published
    9 June 2015

  3. Collection and publication of data on the outcomes of percutaneous cryotherapy for renal cancer in the long term is encouraged. Further research should compare the long-term outcomes of cryotherapy with those of other treatments for renal cancer.

    cryotherapy for renal cancer Number IPG402 Date issued July 2011 Other details Is this a recommendation for the use

    Research recommendation
    Published
    9 June 2015

  4. Which new (previously not researched) primary prevention interventions (that do not include information provision as a component) are effective and cost effective in preventing skin cancer in the UK? What factors influence effectiveness and cost effectiveness?

    Skin cancer prevention Number PH32 Date issued January 2011 Other details Is this a recommendation for the use

    Research recommendation
    Published
    9 June 2015

  5. Further research designed to investigate differences in health-related quality of life and the clinical effectiveness of bevacizumab in subgroups, such as those with prior taxane exposure, would be particularly useful.

    metastatic breast cancer Number TA214 Date issued February 2011 Other details Is this a recommendation for the use

    Research recommendation
    Published
    9 June 2015

  6. The NxStage System One NX1000‑1 home haemodialysis device for renal replacement therapy in chronic kidney disease (MIB12)

    NICE has developed a medtech innovation briefing (MIB) on The NxStage System One NX1000-1 home haemodialysis device for renal replacement therapy in chronic kidney disease .

    Medtech innovation briefing
    Published
    19 November 2014

  7. How effective and cost effective are interventions which use either a 'total population' or 'high-risk population' approach to preventing type 2 diabetes among people from black and minority ethnic or lower socioeconomic groups?

    community-level interventions Number PH35 Date issued May 2011 Other details Is this a recommendation for the use

    Research recommendation
    Published
    9 June 2015

  8. Further collection of quality of life data from people who are cured and who have experience of amputation and chemotherapy are also needed. Additional data on the health effects on parents, siblings and others with life-threatening illness would also be of value.

    treatment of osteosarcoma Number TA235 Date issued October 2011 Other details Is this a recommendation for the use

    Research recommendation
    Published
    9 June 2015

  9. Research is needed to generate robust and relevant data on the effects of treating people with Alzheimer's disease on both short-term and long-term outcomes, disease progression through relevant health states, and quality of life.

    Alzheimer's disease Number TA217 Date issued March 2011 Other details Is this a recommendation for the use

    Research recommendation
    Published
    9 June 2015

  10. What are the prevalence, risk and protective factors, and course of illness for different combinations of psychosis and coexisting substance misuse (for example, schizophrenia and cannabis misuse or bipolar disorder and alcohol misuse)?

    in healthcare settings Number CG120 Date issued March 2011 Other details Is this a recommendation for the use

    Research recommendation
    Published
    9 June 2015

  11. A trial comparing the long-term effectiveness (beyond 24 weeks) of cilostazol, naftidrofuryl oxalate, pentoxifylline and inositol nicotinate and placebo would be beneficial. It should collect utility data as well as walking distance outcomes.

    peripheral arterial disease Number TA223 Date issued May 2011 Other details Is this a recommendation for the use

    Research recommendation
    Published
    9 June 2015

  12. Which participatory approaches are most effective and cost effective among populations at higher risk of type 2 diabetes? This should consider the awareness, knowledge, understanding and skills of the providers of interventions for people at high risk of developing type 2 diabetes?

    community-level interventions Number PH35 Date issued May 2011 Other details Is this a recommendation for the use

    Research recommendation
    Published
    9 June 2015

  13. The Committee recommends that a study estimating utility values using directly observed health-related quality of life values (such as EQ 5D scores) in patients with myelodysplastic syndromes, chronic myelomonocytic leukaemia or acute myeloid leukaemia is conducted.

    acute myeloid leukaemia Number TA218 Date issued March 2011 Other details Is this a recommendation for the use

    Research recommendation
    Published
    9 June 2015

  14. What are the most effective and cost effective ways of developing, implementing and assessing tailored and culturally appropriate community-level interventions to prevent type 2 diabetes among people at high risk? This includes people from a range of black and minority ethnic groups and those from lower socioeconomic communities.

    community-level interventions Number PH35 Date issued May 2011 Other details Is this a recommendation for the use

    Research recommendation
    Published
    9 June 2015

  15. Current evidence on the efficacy and safety of distal iliotibial band lengthening for refractory greater trochanteric pain syndrome is inadequate in quantity and quality. Therefore this procedure should only be used in the context of research. Research studies should clearly define patient selection, and outcomes should include measures of function and quality of life.

    trochanteric pain syndrome Number IPG375 Date issued January 2011 Other details Is this a recommendation for the use

    Research recommendation
    Published
    9 June 2015